OTC, Prescription, and Pharamacy Online Pharmacies, and more, a very professional site with the latest updates. The only drawback in this site is that there is no information given in English other than the names of drugs and prices. **www.drugsstore.pk** —The Drugs Store is an online pharmacy based in Pakistan and has an impressive database with links to a well-organized set of pages that include information about a number of drugs, including drugs for treatment of ailments such as HIV, treatment for common diseases like flu, and other medicines such as antibiotics and drugs for children. ### **References** 1. Iqbal, S. S. & Sattar, A. 2010. _A comprehensive review of the history of pharmacy and its practitioners in Pakistan_. J Pharmacy and Pharm Care, 4:3, pp. 146–154. Retrieved from: . 2. Khan, I. S. M. A. & Hussain, S. 2008. _Pharmacy and pharmacists: A historic perspective_. Pharmacy and Medical Terminology, 9:4, pp. 26–29. Retrieved from: . 3. National Centre for Biotechnology Information (NCBI), U.S. Department of Health and Human Services, 2007. _PharmGKB—Pharmacogenomics Knowledgebase_. Retrieved from: 4. Yen, J. M. & Ng, J. 2008. _Pharmacogenomics: An introduction to the genetic basis of drug action_. Humana Press, Totowa, NJ, pp. 34–46. Retrieved from: . 5. U.S. Food and Drug Administration (FDA), 2007. _Medical products subject to regulatory action_. 6. U.S. Food and Drug Administration (FDA), 2004. _NDA Approval letters—November 2004_. 7. Wallach, D. J., Agranoff, B. E., & Quackenbush, V. 2001. _Medical genetics: Understanding disease with DNA_. OUP USA, New York, pp. 16–19. Retrieved from: . 8. U.S. Food and Drug Administration (FDA), 2014. _Federal Register_. 80, pp. 1–4 Retrieved from: . 9. Yen, J. M. & Ng, J. 2008. _Pharmacogenomics: An introduction to the genetic basis of drug action_. Humana Press, Totowa, NJ, pp. 34–46. Retrieved from: . 10. World Health Organization, 2011. _Global database on antibiotic resistance—WHO database on global drug resistance (WHONDR-6)_. Retrieved from: . 11. WHO, WHO Collaborating Centre for Drug Monitoring (CCDM), 2011. _WHO essential medicines and dosage forms directory. 6th edition_. Retrieved from: . 12. World Health Organization (WHO), 2007. _Drug use and safety_. Retrieved from: . 13. Yen, J. M. & Ng, J. 2008. _Pharmacogenomics: An introduction to the genetic basis of drug action_. Humana Press, Totowa, NJ, pp. 34–46. Retrieved from: . 14. U.S. Food and Drug Administration (FDA), 2013. _Generic Drug User Fee Act (GDUFA) annual report_. . 15. Yen, J. M. & Ng, J. 2008. _Pharmacogenomics: An introduction to the genetic basis of drug action_. Humana Press, Totowa, NJ, pp. 34–46. Retrieved from: . 16. U.S. Food and Drug Administration (FDA), 2009. _Prescription Drug User Fee Act of 2003 (PDUFA)_. Retrieved from: . 17. FDA, 1997. _Final monograph for generic products and FDA supplements_. Retrieved from: . 18. Drugs and Cosmetics Act, 1992, Section 14(6). Retrieved from: . 19. Drugs and Cosmetics Act, 1992. Section 13(6). Retrieved from: . 20. Drugs and Cosmetics Act, 1992. Section 19(5). Retrieved from: . 21. Pakistan Medicines and Healthcare Products Regulatory Agency, Department of Pharmaceuticals and Poisons. _Pakistan Drug Formulary (PDFs)—July/October 2006_. Retrieved from: . 22. Yen, J. M. & Ng, J. 2008. _Pharmacogenomics: An introduction to the genetic basis of drug action_. Humana Press, Totowa, NJ, pp. 34–46. Retrieved from: . 23. Yen, J. M. & Ng, J. 2008. _Pharmacogenomics: An introduction to the genetic basis of drug action_. Humana Press, Totowa, NJ, pp. 34–46. Retrieved from: . 24. Yen, J. M. & Ng, J. 2008. _Pharmacogenomics: An introduction to the genetic basis of drug action_. Humana Press, Totowa, NJ, pp. 34–46. Retrieved from: . 25. Yen, J. M. & Ng, J. 2008. _Pharmacogenomics: An introduction to the